Novo Nordisk Slides Despite Raised Guidance: What Worried Investors?
Novo Nordisk raised its 2026 outlook but shares fell as Wegovy pill sales, CagriSema data and competition from Eli Lilly disappointed investors.
FINANCEMARKETS.INFO
Novo Nordisk raised its 2026 outlook but shares fell as Wegovy pill sales, CagriSema data and competition from Eli Lilly disappointed investors.
Eli Lilly raises its 2026 revenue outlook after Mounjaro and Zepbound sales soar. Analysis of production, margins, pipeline, Novo Nordisk competition and valuation.
Disney beat profit estimates as streaming income doubled and parks strengthened. We examine revenue, films, TikTok, guidance and valuation.
AMD revenue rose 50% and data-center sales doubled, but its shares fell as margins, guidance and Nvidia competition disappointed investors.
SpaceX revenue jumped 92%, but shares fell as $18.4 billion of capital spending, cash burn and the IPO lock-up worried investors.
Glencore’s EBITDA reached $10.1 billion as trading profits surged. The miner announced a special distribution, buyback and Australian listing.
Shopify delivered more than 30% growth across revenue, gross merchandise volume and gross profit, while free-cash-flow margins improved. The results justify greater confidence in […]
Shopify, Eli Lilly, Disney, Glencore and Siemens Energy delivered some of the strongest corporate updates on Wednesday. AMD reported rapid AI-driven growth but failed to meet elevated investor expectations, while Novo Nordisk fell despite raising its full-year forecasts.
Caterpillar, Palantir and BP lead today’s earnings movers, while BioNTech, Zalando, Lufthansa and NRG fall after weaker updates.